Chairs: Hervé Dombret, Arnold Ganser, Jorge Sierra, Wendy Stock

Date: Tuesday 30 June - Thursday 2 July 2020
Venue: Online Conference

European School of Haematology (ESH) How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management on the basis of presentation, analysis and discussion of real clinical cases.

Novel and still evolving insights into the biology and diagnosis of acute leukaemias, including acute myeloid leukaemias (AMLs) and acute lymphoblastic leukaemia (ALL), are translating into new therapeutic options with recent drug approvals for the treatment of newly-diagnosed as well as relapsed/refractory disease.

The programme of this “2nd How to Diagnose and Treat: Acute Leukaemia” meeting will address the integration of genomic analysis and cutting-edge techniques for routine diagnosis, gene mutation-based therapies and new standard treatment algorithms, allogeneic haematopoietic stem cell (HSCT) transplantation and innovative immunotherapies, as well as the diagnosis and management of rare acute leukaemia subtypes.

ESH How to Diagnose and Treat conferences are clinically oriented meetings that focus on the state-of-the-art and future perspectives. One major objective is to promote interaction between the speakers and participants.

The meeting will include plenary sessions with plenty of time allocated to general discussion. Case-study sessions will use voting box technology to enhance interactive discussion. Simultaneous Meet the Expert sessions will provide a format for face to face interaction on specific themes between small groups of registered participants and selected members of the faculty.

Posters and Brief Oral Communications:
Registered participants are invited to submit their biology and clinical abstracts, and clinical cases. Selected abstracts will be presented as posters. Selected clinical cases will be presented as brief oral communications or posters.

Call for Abstracts and Clinical Cases: deadline Sunday 12 January 2020

This meeting will be valuable for you if you are looking for:

A cutting-edge scientific programme – from basic science to clinical and therapeutic applications and perspectives
Multiple opportunities for scientific interaction with an international faculty of distinguished experts
An emphasis on critical discussion
The meeting will provide clinicians and biologists with state-of-the-art recommendations regarding patient care and insights into controversies and new therapeutic perspectives in the field.

This meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior biologists and clinicians (MD, PhD)
  • Clinical residents still in-training
  • Allied health care professionals

Learning objectives:

  • Learn about the modern sets of diagnosis tests needed to optimally manage patients with AML and ALL
  • Review and hierarchise the new treatment standards available to AML and ALL patients for front-line and for salvage therapy
  • Understand the value and role of leukaemic stem cell targeting and measurable residual disease (MRD) levels to stratify acute leukaemia therapy
  • Gain insight into emerging mechanisms associated with clinical resistance and leukaemia escape
  • Understand the effects and place of new immunotherapies with respect to standard or new HSCT procedures

Topics :

  • Rare subsets of acute leukaemia
  • Tracking leukaemic stem cells (LSCs)
  • Routing diagnosis gene expression and mutational profiling
  • Addition of a 3rd agent to frontline 7+3
  • Allogeneic hematopoietic stem cell transplantation (HSCT) - Immunotherapy for acute leukaemia

The programme will include:

  • Plenary Sessions
  • Interactive Case Presentations
  • Roundtables
  • Panel Discussions
  • Debates
  • Poster Presentations
  • Voting boxes

For further information please visit the conference website or email Camille Frank.

External Events

Jun 20
29
30
Jul 20
4
Aug 20
13
23
Sep 20
11
14
18
21
23
25
Oct 20
2
8
9
13
30
Nov 20
6
13
17
18
23
24
26
27
Jan 21
28
Feb 21
2
May 22
13
June 29th 2020
British Society for Haematology at 60: Lessons for…
THIS EVENT HAS BEEN POSTPONED - NEW DATE TBC

One-day conference to highlight the central role played by haematology i…
Details
June 30th 2020
2nd How to Diagnose and Treat Acute Leukaemia
Chairs: Hervé Dombret, Arnold Ganser, Jorge Sierra, Wendy Stock
Details
July 4th 2020
Sickle Cell Awareness Day
Sickle cell continues to affect many and due to lack of basic awareness many are left without any support. Join the figh…
Details
August 13th 2020
Undergraduate Pathology Summer School
This annual event, held every August, is open to medical students in any year of training, offering the opportunity to f…
Details
August 23rd 2020
European Microscopy Congress 2020
The European Microscopy Congress is known for being the largest European stage for cross-disciplinary research and emc20…
Details
September 11th 2020
20th Meeting of the European Association for Haema…
The EAHP is committed to improving haematopathology knowledge and raising the standards of education, research and clini…
Details
September 14th 2020
Symposium on the contributions by the Anthony Nola…
An outstanding symposium for BMT and future of haematological malignancies in innovative cell therapies.
Details
September 14th 2020
FRCPath Haemostasis and Thrombosis Training and Up…
The course is suitable for SpRs preparing for the part 2 FRCPath examination but is also suitable for clinicians, scient…
Details
September 18th 2020
OXFORD: National Thrombosis Conference 2020
Venous thromboembolism (VTE) remains a major disease burden resulting in premature death, long-term health issues and co…
Details
September 21st 2020
Haematology in Obstetrics
An intensive, enjoyable course, comprising didactic teaching on major topics together with interactive sessions and work…
Details
September 23rd 2020
Masterclass: The Management of Venous Thromboembol…
THIS EVENT HAS BEEN POSTPONED - DATE TBC
Venous thromboembolism (VTE) remains a major disease burden resulting in prema…
Details
September 25th 2020
All England Thrombosis UK & NNMN Conference 2020
Venous thromboembolism (VTE) remains a major disease burden resulting in premature death, long-term health issues and co…
Details
October 2nd 2020
22nd Annual John Goldman Conference on Chronic Mye…
Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause - Co-organisers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Mi…
Details
October 8th 2020
All Ireland National Thrombosis Conference 2020
Venous thromboembolism (VTE) remains a major disease burden resulting in premature death, long-term health issues and co…
Details
October 9th 2020
5th Translational Research Conference: Multiple My…
Chairs: Kenneth C. Anderson, Maria-Victoria Mateos, Philippe Moreau
Details
October 13th 2020
All Scotland National Thrombosis Conference 2020
Venous thromboembolism (VTE) remains a major disease burden resulting in premature death, long-term health issues and co…
Details
October 30th 2020
The Management of Venous Thromboembolism Conferenc…
Venous thromboembolism (VTE) remains a major disease burden resulting in premature death, long-term health issues and co…
Details
November 6th 2020
How to Diagnose and Treat: Lymphoma
Chairs: Christian Buske, Catherine Thieblemont, Anas Younes
Details
November 6th 2020
Post-transplant Managing Quality of Life Symposium…
This symposium will highlight the importance of a multidisciplinary approach for improving patients Quality of Life post…
Details
November 13th 2020
Translational Research Conference: Bone Marrow Fai…
Chairs: Tim Brümmendorf, Carlo Dufour, Inderjeet Dokal, Régis Peffault de la Tour, Marc H.G.P Raaijmakers, Neal Young
Details
November 17th 2020
1st Translational Research Conference: Chronic Lym…
Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek
Details
November 18th 2020
A User Guide to Cancer Immunotherapy
This event will provide an overview of cancer immunotherapy, with a focus on the recognition and management of immune-me…
Details
November 23rd 2020
Introduction to Haematology Care
This study day will provide a basic understanding of caring for haematology patients and expand knowledge on the disease…
Details
November 24th 2020
The Royal Marsden Haemato-Oncology Study Day
This study day is aimed at healthcare professionals involved in the treatment of patients with haematological cancers, p…
Details
November 26th 2020
Transplant Complications and GVHD
Updates in transplant complications and GVHD suitable for any member of the BMT team
Details
November 26th 2020
Advances in Transfusion Medicine
There are exciting ongoing developments in transfusion medicine and science with high quality research supporting eviden…
Details
November 27th 2020
HMDS Annual Haematopathology Update Day
The study day will focus on the recent advances seen within myeloma, chronic lymphocytic leukemia and myeloproliferation…
Details
January 28th 2021
7th Translational Research Conference: Myelodyspla…
Chairs: Pierre Fenaux, Uwe Platzbecker, Mikkael Sekeres
Details
February 2nd 2021
Targeted Treatments for Haematological Cancers
This course describes the unique cellular and genetic features of haematological cancers and covers a diverse range of t…
Details
May 13th 2022
9th Translational Research Conference: Myeloprolif…
Chairs: Jean-Jacques Kiladjian, Ross Levine, Alessandro Vannucchi
Details